Case number 1:21-cv-01616
Merck Sharp & Dohme Corp. v. ScieGen Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 22, 2021 | 9 | Proposed Consent Judgment (3) Docket Text: PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/22/2021 (nms). |
| Nov 22, 2021 | 10 | Consent Judgment (3) Docket Text: CONSENT JUDGMENT. Signed by Judge Richard G. Andrews on 11/22/2021. (nms) |
| Nov 22, 2021 | 11 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # (1) Judgment)(nms) |
| Nov 22, 2021 | 11 | Judgment (3) |
| Nov 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Robert Silver, filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 11/19/2021. (nms) |
| Nov 19, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Robert S. Silver for Bactolac Pharmaceutical Inc. and ScieGen Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Nov 19, 2021 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Patricia Smink Rogowski on behalf of All Defendants (Rogowski, Patricia) |
| Nov 19, 2021 | 8 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert Silver - filed by Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals, Inc.. (Rogowski, Patricia) |
| Nov 17, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) |
| Nov 16, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Bactolac Pharmaceutical Inc. on 11/16/2021; ScieGen Pharmaceuticals, Inc. on 11/16/2021. (Attachments: # (1) Summons Issued)(myr) |
| Nov 16, 2021 | 6 | Summons Issued (2) |
| Nov 15, 2021 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Bactolac Pharmaceutical Inc., ScieGen Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3743365.) - filed by Merck Sharp & Dohme Corp. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(myr) |
| Nov 15, 2021 | 1 | Exhibit A (18) |
| Nov 15, 2021 | 1 | Civil Cover Sheet (2) |
| Nov 15, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Nov 15, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than October 6, 2021. Date of Expiration of Patent: November 24, 2026 (May 24, 2027 pediatric exclusivity expiration).Thirty Month Stay Deadline: No Earlier than 4/6/2024. (myr) |
| Nov 15, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (myr) |
| Nov 15, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp. (myr) |
| Nov 15, 2021 | 1 | Complaint* (1) |
